In SLE, MDSCs promote Th17 differentiation and exacerbate disease severity,44, 45 while in RA, they produce proinflammatory cytokines (e.g., TNF‐α, IL‐1β) and induce Th17 differentiation.46, 47, 48. Here, IL1B is linked to systemic lupus erythematosus.